Respiratorius develops pharmaceutical drugs to treat two of the most common and fastest growing diseases in the world: Chronic Obstructive Pulmonary Disease (COPD) and asthma. Every year, millions of people all over the world develop these diseases, and still there are no effective medicines, especially for the treatment of COPD, but also to a certain extent, severe asthma.
With our innovative therapeutic approach to relaxing the airways, it is our ambition to improve the quality of life for all of these patients within a not too distant future.
News